BRCA1 and BRCA2 gene mutations, confirmed to be linked to breast cancer in families [44, 45], confer a 3.8- and 8.6-fold increased risk of developing prostate cancer, respectively [14, 15]. This evidence concerns the gene BRCA2 and Familial prostate cancer.